Benzodiazepine dependence could be prevented by adherence to recommendations for
short-term prescribing (2–4 weeks only when possible). Withdrawal of benzodiazepines …

Panic disorder is a common mental disorder that affects up to 5% of the population at some
point in life. It is often disabling, especially when complicated by agoraphobia, and is …

In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …

These British Association for Psychopharmacology guidelines cover the range and aims of
treatment for anxiety disorders. They are based explicitly on the available evidence and are …

The Massachusetts General Hospital is widely respected as one of the world's premier
psychiatric institutions. Now, preeminent authorities from MGH present the newly updated …

Background Panic disorder can be treated with pharmacotherapy, psychotherapy or in
combination, but the relative merits of combined therapy have not been well established …

Although most individuals with recurrent headache disorders in the general population do
not experience severe psychopathology, population‐based studies and clinical …

Objective: Although effective treatments exist, individuals with depressive and anxiety
disorders can remain ill for years. Little is known regarding mental health status and …

To date, no large‐scale, controlled trial comparing a serotonin–norepinephrine reuptake
inhibitor and selective serotonin reuptake inhibitor with placebo for the treatment of panic …

Selective serotonin reuptake inhibitors and venlafaxine are currently considered as first-line
agents for patients with panic disorder (PD). However, a systematic comparison of newer …